NASDAQ: PRPH
Prophase Labs Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PRPH stock forecasts and price targets.

Forecast return on equity

Is PRPH forecast to generate an efficient return?

Company
N/A
Industry
70.97%
Market
-49.26%

Forecast return on assets

Is PRPH forecast to generate an efficient return on assets?

Company
N/A
Industry
21.46%

PRPH earnings per share forecast

What is PRPH's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.56

PRPH revenue growth forecast

How is PRPH forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
164.81%
Industry
5.28%
Market
10.8%
PRPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRPH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
PRPH$0.33N/AN/A
MDXH$3.29N/AN/A
ADVB$0.42N/AN/A
BIAF$0.25N/AN/A
XWEL$1.12N/AN/A

Prophase Labs Stock Forecast FAQ

What is PRPH's earnings growth forecast for 2025-2025?

(NASDAQ: PRPH) Prophase Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 15.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Prophase Labs's earnings in 2025 is -$41,452,000.

In 2025, PRPH is forecast to generate -$23,263,075 in earnings, with the lowest earnings forecast at -$23,263,075 and the highest earnings forecast at -$23,263,075.

If you're new to stock investing, here's how to buy Prophase Labs stock.

What is PRPH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PRPH) forecast ROE is N/A, which is considered weak.

What is PRPH's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: PRPH) Prophase Labs's current Earnings Per Share (EPS) is -$1.94. In 2025, PRPH's EPS is forecast to hit -$0.56 (min: -$0.56, max: -$0.56).

What is PRPH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PRPH) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 21.46%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.